Cargando…

Can NT-proBNP Levels Be an Early Biomarker of Reduced Left Ventricular Ejection Fraction in Preterm Infants?

Background/Objective: N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a cardiac natriuretic hormone that cardiomyocytes release in response to ventricular stretch. It helps with the diagnosis of heart failure in adults, but this application in preterm infants has rarely been reported. This...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Ya-Lan, Hung, Yi-Li, Shen, Chung-Min, Chen, Yung-Chuan, Hsieh, Wu-Shiun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320069/ https://www.ncbi.nlm.nih.gov/pubmed/35883986 http://dx.doi.org/10.3390/children9071002

Ejemplares similares

NT-proBNP as predictor of major cardiac events after renal transplantation in patients with preserved left ventricular ejection fraction
por: Schwab, Sebastian, et al.
Publicado: (2023)

NT-proBNP and diastolic left ventricular function in patients with Marfan syndrome
por: Gehle, Petra, et al.
Publicado: (2016)

Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction
por: Salah, Khibar, et al.
Publicado: (2019)

Die Biomarker BNP und NT‑proBNP
por: Oremek, G. M., et al.
Publicado: (2023)

Differences in NT‐proBNP Response and Prognosis in Men and Women With Heart Failure With Reduced Ejection Fraction
por: Daubert, Melissa A., et al.
Publicado: (2021)

NT-proBNP in Children With Left to Right Shunt and Dilated Cardiomyopathy
por: Koura, Hala Mahmoud, et al.
Publicado: (2016)

Baseline NT-proBNP and responsiveness to autonomic regulation therapy in patients with heart failure and reduced ejection fraction
por: Anand, Inder, et al.
Publicado: (2020)

Vericiguat and NT‐proBNP in patients with heart failure with reduced ejection fraction: analyses from the VICTORIA trial
por: Senni, Michele, et al.
Publicado: (2022)

Agreement of BNP and NT-proBNP and the influence of clinical and laboratory variables
por: Curiati, Milena Novaes Cardoso, et al.
Publicado: (2013)

The Role of NT-proBNP in the Diagnosis of Ventricular Arrhythmias in Patients with Systemic Sclerosis
por: MURESAN, Lucian, et al.
Publicado: (2017)

Clinical characteristics and outcomes of patients hospitalized with heart failure with preserved ejection fraction and low NT-proBNP levels
por: Chen, Yu-Yi, et al.
Publicado: (2023)

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
por: Palazzuoli, A, et al.
Publicado: (2010)

The Ability of Heart Failure Specialists to Accurately Predict NT-proBNP Levels Based on Clinical Assessment and a Previous NT-proBNP Measurement
por: Sedlak, Tara L, et al.
Publicado: (2008)

Use of NT-proBNP in weaning from mechanical ventilation
por: Martini, A, et al.
Publicado: (2011)

NT-proBNP and the diagnosis of exercise-induced myocardial ischaemia
por: De Greef, Jacques, et al.
Publicado: (2008)

Rise and fall of NT-proBNP in aortic valve intervention
por: Hultkvist, Henrik, et al.
Publicado: (2018)

Highly sensitive detection of NT-proBNP by molecular motor
por: Zhang, Jie, et al.
Publicado: (2016)

In-hospital mortality is associated with high NT-proBNP level
por: Benmachiche, Malik, et al.
Publicado: (2018)

Admission NT-ProBNP in Myocardial Infarction: an Alert Sign?
por: da Silva, Luís Beck
Publicado: (2019)

The Potential Role of Salivary NT-proBNP in Heart Failure
por: Rammos, Aidonis, et al.
Publicado: (2023)

Comparison of predictive value of NT-proBNP, sST2 and MMPs in heart failure patients with different ejection fractions
por: Pan, Wei, et al.
Publicado: (2020)

Serum NT-proBNP and TUG1 as novel biomarkers for elderly hypertensive patients with heart failure with preserved ejection fraction
por: Zhang, Shuang, et al.
Publicado: (2021)

The age, NT-proBNP, and Ejection Fraction Score as a Novel Predictor of Clinical Outcomes in CAD Patients After PCI
por: Fan, Lei, et al.
Publicado: (2022)

Left Ventricular Dysfunction and Plasmatic NT-proBNP Are Associated with Adverse Evolution in Respiratory Syncytial Virus Bronchiolitis
por: Rodriguez-Gonzalez, Moises, et al.
Publicado: (2019)

BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
por: Lewis, Robert A., et al.
Publicado: (2020)

Age, Gender and Load-Related Influences on Left Ventricular Geometric Remodeling, Systolic Mid-Wall Function, and NT-ProBNP in Asymptomatic Asian Population
por: Chen, Chi, et al.
Publicado: (2016)

Repositioning and optimization of left ventricular lead position in nonresponders to cardiac resynchronization therapy is associated with improved ejection fraction, lower NT-proBNP values, and fewer heart failure symptoms
por: Borgquist, Rasmus, et al.
Publicado: (2022)

NT-proBNP as a biomarker of right ventricular dilatation and pulmonary regurgitation in Tetralogy of Fallot
por: Valverde, Israel, et al.
Publicado: (2015)

Does dipyridamole-induced ischaemia affect NT-proBNP secretion?
por: De Greef, Jacques, et al.
Publicado: (2007)

Using NT-proBNP as a criterion for heart failure hospitalization
por: Tamizifar, Babak, et al.
Publicado: (2012)

The relationship between NT-proBNP and Depression in Patients with Heart Failure
por: Gao, Ying–Hui, et al.
Publicado: (2017)

NT-proBNP as a biomarker for hyperdynamic circulation in decompensated cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2018)

NT-proBNP and postoperative heart failure in surgery for aortic stenosis
por: Jiang, Huiqi, et al.
Publicado: (2019)

Significance of NT-proBNP and High-Sensitivity Troponin in Friedreich Ataxia
por: Legrand, Lise, et al.
Publicado: (2020)

Prognostic value of NT-proBNP in patients with severe COVID-19
por: Gao, Lei, et al.
Publicado: (2020)

Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
por: Lau, Chin-Shern, et al.
Publicado: (2022)

LSPR-Based Aptasensor for Rapid Urinary Detection of NT-proBNP
por: António, Maria, et al.
Publicado: (2023)

Exploring the NT-proBNP expression in Premature Infants with Patent Ductus Arteriosus (PDA) by Echocardiography
por: Shi, Yunlong, et al.
Publicado: (2021)

BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine
por: Cao, Zhipeng, et al.
Publicado: (2019)

Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors
por: Alawieh, Hussein, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5t8ahpfg6vdioem9hb581hvubo